Remicade Biosimilar Market By Disease Indication (Crohn’s disease, Rheumatoid Arthritis, Ankylosing Spondylitis, Psoriatic Arthritis, Ulcerative Colitis, Plaque Psoriasis) and By Region - Global and Regional Industry Overview, Market Intelligence, Comprehensive Analysis, Historical Data, and Forecasts 2022 – 2028

The global Remicade biosimilar market size was worth USD 1,628.3 million in 2021 and is estimated to grow to USD 10,257.7 million by 2028, with a CAGR of 35.9.

全球雷米法生物类似物市场规模于2021年达到16.283亿美元，预计到2028年将增长至102.577亿美元，年复合增长率达到35.9%。